Thomas Stephen Basilinsider trades

In SEC Form 4 filings, Thomas Stephen Basil is listed as Director of Climb Bio, Inc. (CLYM). In the last 90 days, Thomas Stephen Basil sold $1.37M of Climb Bio, Inc. (CLYM) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
CLYMClimb Bio, Inc.	Director	1	Sep 17

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-17

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
CLYMClimb Bio, Inc.	Sep 15	Sep 17	S	100,000	$13.67	Sale −$1,366,820	467,969	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.